Active Biotech AB (publ) (LON: 0GQU)
London
· Delayed Price · Currency is GBP · Price in SEK 0.114
0.00 (0.00%)
At close: Jan 21, 2025
Active Biotech AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 6.2 | 36.22 | 41.8 | 53.13 | 26.21 | 59.68 | Upgrade
|
| Cash & Short-Term Investments | 6.2 | 36.22 | 41.8 | 53.13 | 26.21 | 59.68 | Upgrade
|
| Cash Growth | 10.71% | -13.35% | -21.34% | 102.70% | -56.08% | 133.57% | Upgrade
|
| Accounts Receivable | - | - | - | - | 0.28 | 0.84 | Upgrade
|
| Other Receivables | 4.4 | 1.26 | 0.95 | 1.19 | 1.23 | 1.77 | Upgrade
|
| Receivables | 4.4 | 1.26 | 0.95 | 1.19 | 1.51 | 2.61 | Upgrade
|
| Prepaid Expenses | - | 1.24 | 1.38 | 1.53 | 1.5 | 1.47 | Upgrade
|
| Other Current Assets | 0.1 | - | - | - | 1.06 | - | Upgrade
|
| Total Current Assets | 10.7 | 38.71 | 44.12 | 55.86 | 30.28 | 63.76 | Upgrade
|
| Property, Plant & Equipment | 3.5 | 4.72 | 6.26 | 0.95 | 1.87 | 3.19 | Upgrade
|
| Other Intangible Assets | 0.2 | 0.25 | 0.25 | - | - | - | Upgrade
|
| Other Long-Term Assets | 0.5 | 0.38 | 0.38 | 0 | 0 | 0 | Upgrade
|
| Total Assets | 14.9 | 44.05 | 51.01 | 56.8 | 32.16 | 66.95 | Upgrade
|
| Accounts Payable | - | 3.17 | 3.53 | 2.76 | 2.85 | 5.6 | Upgrade
|
| Accrued Expenses | - | 5.36 | 6.37 | 5.98 | 4.75 | 4.03 | Upgrade
|
| Current Portion of Leases | - | 1.55 | 1.61 | 0.76 | 1.31 | 1.25 | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | - | 0.03 | Upgrade
|
| Other Current Liabilities | 11.5 | 0.3 | 0.56 | 0.41 | 0.44 | 0.26 | Upgrade
|
| Total Current Liabilities | 11.5 | 10.38 | 12.06 | 9.9 | 9.35 | 11.17 | Upgrade
|
| Long-Term Leases | 1.9 | 3 | 4.43 | 0.23 | 0.69 | 2 | Upgrade
|
| Total Liabilities | 13.5 | 13.38 | 16.49 | 10.13 | 10.04 | 13.17 | Upgrade
|
| Common Stock | 1.4 | 1.87 | 1.37 | 1.13 | 0.75 | 0.75 | Upgrade
|
| Additional Paid-In Capital | - | 3,472 | 3,431 | 3,386 | 3,312 | 3,312 | Upgrade
|
| Retained Earnings | - | -3,443 | -3,398 | -3,340 | -3,291 | -3,259 | Upgrade
|
| Shareholders' Equity | 1.4 | 30.67 | 34.51 | 46.67 | 22.11 | 53.78 | Upgrade
|
| Total Liabilities & Equity | 14.9 | 44.05 | 51.01 | 56.8 | 32.16 | 66.95 | Upgrade
|
| Total Debt | 1.9 | 4.55 | 6.04 | 0.99 | 2 | 3.25 | Upgrade
|
| Net Cash (Debt) | 4.3 | 31.67 | 35.76 | 52.15 | 24.21 | 56.43 | Upgrade
|
| Net Cash Growth | 95.45% | -11.42% | -31.43% | 115.38% | -57.09% | - | Upgrade
|
| Net Cash Per Share | 0.01 | 0.12 | 0.15 | 0.24 | 0.14 | 0.39 | Upgrade
|
| Filing Date Shares Outstanding | 361.81 | 361.74 | 264.89 | 217.97 | 217.97 | 145.24 | Upgrade
|
| Total Common Shares Outstanding | 361.81 | 361.74 | 264.89 | 217.97 | 145.24 | 145.24 | Upgrade
|
| Working Capital | -0.8 | 28.33 | 32.06 | 45.95 | 20.93 | 52.59 | Upgrade
|
| Book Value Per Share | 0.00 | 0.08 | 0.13 | 0.21 | 0.15 | 0.37 | Upgrade
|
| Tangible Book Value | 1.2 | 30.42 | 34.27 | 46.67 | 22.11 | 53.78 | Upgrade
|
| Tangible Book Value Per Share | 0.00 | 0.08 | 0.13 | 0.21 | 0.15 | 0.37 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.